Diagnostic and Prognostic Values of KRAS Mutations on EUS-FNA Specimens and Circulating Tumor DNA in Patients With Pancreatic Cancer

INTRODUCTION: The ability of carbohydrate antigen 19-9 (CA19-9) to differentiate pancreatic cancer from other benign pancreatic lesions is unsatisfactory. This study explored the diagnostic value of KRAS gene mutations and plasma circulating tumor DNA (ctDNA) in patients with pancreatic cancer. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ronghua, Zhao, Yuchong, Wang, Yun, Zhao, Zhenxiong, Chen, Qian, Duan, Yaqi, Xiong, Si, Luan, Zhou, Wang, Jinlin, Cheng, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132521/
https://www.ncbi.nlm.nih.gov/pubmed/35351843
http://dx.doi.org/10.14309/ctg.0000000000000487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132521/
https://www.ncbi.nlm.nih.gov/pubmed/35351843
http://dx.doi.org/10.14309/ctg.0000000000000487

Ejemplares similares